ScholarWorks@Korea University: Park, Moon Ho

Detailed Information

Park, Moon Ho (박문호)

College of Medicine (Department of Medical Science)

Research Area

Tel 산6547
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Alzheimer&apos:15||s disease:14||Dementia:8||cognition:5||dementia:5||Schizophrenia:4||GRIA4:3||GRIA2:3||GRIA1:3||Korean:3||MiniMental State Examination:3||screening:3||Parkinson&apos:3||Serious game:3||mild cognitive impairment:3||Parkinsonism:3||Mild cognitive impairment:3||Bipolar disorder:2||KDSQ:2||Cognitive impairment:2||Major depressive disorder:2||cognitive dysfunction:2||Antipsychotics:2||Needs:2||plasma:2||sarcopenia:2||mortality:2||Vertigo:2||Cerebellum:2||Brainderived neurotrophic factor:2||urinary incontinence:2||depression:2||Alzheimer’s disease:2||Major depression:2||biomarker:2||African American:2||Acceptance:2||IQCODE:2||s disease (AD):2||left atrial volume index:1||exercise:1||Multicategory classification:1||GDS15:1||cognitive impairment:1||gyrosensor:1||Atherosclerosis:1||gait:1||spatiotemporal variable:1||Computerized assessment:1||Primary care:1||Classifying:1||Olfactory dysfunction:1||대공협착:1||Rotational vertebral artery compression:1||Renal function:1||frontotemporal dementia:1||Hyperparathyroidism:1||Hypercalcemia:1||Brain plasticity:1||Uremic encephalopathy:1||biomarkers:1||tolerability.:1||somatoform disorder:1||Toxicology:1||intoxication:1||the elderly:1||cerebrospinal fluid:1||Sensory trick:1||ABCB1:1||SYN2:1||vitamin D:1||progressionCRP:1||education:1||5 &apos:1||DNA methylation:1||CLINICAL IMPROVEMENT:1||BIPOLAR DISORDER:1||Region:1||Tryptophan hydroxylase 2:1||Crosssectional study:1||Obesity:1||AMPK:1||Clozapine:1||Diabetic polyneuropathy:1||Splenium:1||Hepatitis A virus:1||Poliosis:1||staging:1||cognitive function:1||Immune:1||Nuclear factorkappa B:1||knowledge:1||Ischemic stroke:1||Validation:1||motor:1||Status epilepticus:1||Lentiform fork sign:1||mild cognitive impairment (MCI):1||Sciatica:1||Vestibulopathy:1||Internal auditory artery:1||Age:1||normative data:1||age:1||Glutamate receptors:1||Bilateral occipital infarction:1||EEG:1||s:1||intrathoracic pressure:1||Attitude:1||FAST:1||carbonic anhydrase II:1||cognitive training:1||s diseases:1||Gonadotropinreleasing hormone:1||atherosclerosis:1||cell survival:1||Atherosclerotic plaque:1||Dementia support center:1||diastolic blood pressure:1||embolic stroke of undetermined source:1||finger tapping:1||Ttype calcium channel:1||anxiety:1||classifying:1||brief psychiatric rating scale:1||MFN2:1||Conitive intervention:1||cholinesterase inhibitors:1||predictors.:1||SUMO1:1||detrusor overactivity:1||intracranial pressure:1||bipolar disorder:1||Hydrocephalus:1||elder:1||Cervical dystonia:1||Untranslated region:1||Activities of daily living:1||Amnestic mild cognitive impairment (aMCI):1||body composition:1||obesity:1||IL8:1||stroke:1||embolism:1||CaMKK:1||Cutaneous silent period:1||Nerve conduction study:1||TAC:1||AD:1||severe dementia:1||SNP:1||carotid artery:1||ultrasonography:1||calcium:1||Hypertension:1||betasite amyloid precursor protein cleaving enzyme:1||Carotid intimamedia thickness:1||Minor depressive disorder:1||median nerve:1||Druginduced parkinsonism:1||중추성자세안진:1||progression:1||subjective memory:1||Neuropsychological Tests:1||Urinary Bladder:1||Epileptic seizures:1||rivastigmine transdermal patch:1||18F2fluoro2deoxyDglucose positron emission tomography.:1||Cerebral hemosiderosis:1||depressive disorder:1||Vestibuloocular reflex:1||Head impulse test:1||clinical studies:1||Stroke:1||Mirror movement:1||Cerebral venous thrombosis:1||clinical trial:1||CLOCK:1||CPLX2:1||NRG1:1||visceral obesity:1||MAJOR DEPRESSIVE DISORDER:1||DAOA:1||clinical improvement:1||schizophrenia:1||skeletal muscle mass:1||Hyponatremia:1||autonomic nervous system:1||Cerebral microbleeds:1||Incidence:1||National health insurance service:1||Montreal Cognitive Assessment:1||Machine learning:1||Alzheimer disease:1||Brain:1||Ncadherin:1||Soluble amyloid precursor proteins alpha (sAPP alpha):1||biomedical engineering device:1||carpal tunnel syndrome:1||equation:1||Screening:1||Foramen magnum stenosis:1||physical activity:1||Pregabalin:1||Gabapentin:1||Computer Assessment of Mild Cognitive Impairment (CAMCI):1||Glufosinate ammonium:1||urodynamics:1||Education:1||orthostatic headache:1||Carotid plaque:1||Spinal cord tumor:1||ABCB4:1||lexical verbal fluency:1||treatment response:1||Frequency:1||Dysautonomia:1||Elderly Koreans:1||transcranial brain sonography:1||Encephalopathy:1||Primary progressive aphasia:1||communitydwelling elderly Korean:1||MCI:1||Hypergonadotropic Hypogonadism:1||heart rate variability:1||KMMSE:1||neurons:1||betaamyloid:1||Carotid arteries:1||Policy:1||Conversion:1||free fatty acid:1||potential embolic sources:1||quality of life:1||Cerebrospinal fluid:1||Soluble amyloid precursor proteins beta (sAPP beta):1||Subthreshold depression:1||Gastroprokinetic drug:1||Negative myoclonus:1||memory:1||behavioural symptoms:1||Lower Urinary Tract Symptoms:1||Mitochondrial fusion:1||Cognition training:1||misdiagnosis:1||Subarachnoid hemorrhage:1||suicidal ideation:1||parkinsonism:1||Normative data:1||Elders:1||Intimamedia thickness:1||Homocysteine:1||attitude:1||Vision:1||elders:1||BACE1:1||Microglial cells:1||Caregiver:1||Complex visual hallucination:1||Spectral power:1||Smallfiber neuropathy:1||Spinocerebellar Ataxia Type 2:1||mitogenactivated protein kinase 1:1||Koreans:1||apolipoprotein E:1||Plasma biomarker:1||mild cognitive decline:1||MMSE:1||Timeofflight magnetic resonance angiography:1||SWEDD:1||Transcranial sonography:1||회전성척추동맥압:1||Central positional nystagmus:1||Videooculography:1||Korean dementia screening questionnaire:1||reversion:1||skin discolouration:1||Lexical verbal fluency:1||Orthostatic tremor:1||survey:1||CPLX1:1||Brain infarction:1||neurological manifestation:1||DAMINO ACID OXIDASE ACTIVATOR (DAOA):1||TREATMENT RESPONSE:1||Osmotic demyelination:1||attention:1||questionnaire:1||Depressive symptoms:1||echogenicity:1||Calcium:1||headshaking headache:1||Diabetes mellitus:1||Q Methodology:1||Concomitant esotropia:1||Macrophage:1||diagnostic tool:1||Depression:1||Dissection:1||Echogenicity:1||blood pressure variability:1||MiniMental State Examination (MMSE):1||African Americans:1||Nystagmus:1||Headshaking nystagmus:1||cognitive therapy:1||zirconium:1||HemiparkinsonHemiatrophy syndrome:1||BDNF:1||Mortality:1||informed consent:1||TAP2:1||5HTR1A and GPRIN2:1||Charles Bonnet syndrome:1||restless legs syndrome:1||C2C12 myotubes:1||spontaneous intracranial hypotension:1||Antisperm antibody:1||Neural mechanism:1||visiting nursing services:1||UBC9:1||Dentatorubropallidoluysian atrophy (DRPLA):1||Norms:1||endothelins:1||protein kinase C:1||Arterial stiffness:1||

STATISTICS: Total View :6,915,417; Today View :15,018

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE